A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing

MLA

Yu Zhang, et al. “A Humanized Knockin Mouse Model of Duchenne Muscular Dystrophy and Its Correction by CRISPR-Cas9 Therapeutic Gene Editing.” Molecular Therapy: Nucleic Acids, vol. 29, no. 525–537, Sept. 2022, pp. 525–37. EBSCOhost, https://doi.org/10.1016/j.omtn.2022.07.024.

APA

Yu Zhang, Hui Li, Takahiko Nishiyama, John R. McAnally, Efrain Sanchez-Ortiz, Jian Huang, Pradeep P.A. Mammen, Rhonda Bassel-Duby, & Eric N. Olson. (2022). A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing. Molecular Therapy: Nucleic Acids, 29(525–537), 525–537. https://doi.org/10.1016/j.omtn.2022.07.024

Chicago

Yu Zhang, Hui Li, Takahiko Nishiyama, John R. McAnally, Efrain Sanchez-Ortiz, Jian Huang, Pradeep P.A. Mammen, Rhonda Bassel-Duby, and Eric N. Olson. 2022. “A Humanized Knockin Mouse Model of Duchenne Muscular Dystrophy and Its Correction by CRISPR-Cas9 Therapeutic Gene Editing.” Molecular Therapy: Nucleic Acids 29 (525–537): 525–37. doi:10.1016/j.omtn.2022.07.024.